Table 1.
Country | Study | Years of data | Data | Denominator | Numerator | Findings |
---|---|---|---|---|---|---|
USA | Cai [51] | 2008–2018 | Veterans Affairs database | Veterans (6,493,141) | Incidence of LEA |
Increased overall (12.9 to 18.1 per 10,000 individuals) but declined in women 62% of the increase was in toe amputations |
USA | An [52] | 2003–2014 | Kaiser Permanente database | Incident T2DM cases (135,199) | Incidence of 13 complications and all-cause mortality |
5-year incidence rates declined over time Neuropathy, CKD and CVD were the most common complications |
Spain | López-de-Andrés [53] | 2001–2018 | National hospital discharge database | People with DM | UTI hospitalisation and in-hospital mortality |
From 2001–2003 to 2016–2018 admissions per 100,00 individuals increased from 290.8 to 568.5 for DM and 74.8 to 144.0 for non-DM In-hospital mortality declined over time |
Spain | Orozco-Beltrán [54] | 2005–2015 | National hospital discharge database | People with DM | Hospitalisation due to hypoglycaemia and mortality |
Admissions per 100,000 individuals decreased from 21.5 to 13.2 in women and from 30.2 to 23.7 in men Mortality (per 100,000 individuals) declined from 8.6 to 4.1 in women and from 9.4 to 6.4 in men |
Portugal | Ramalho [55] | 2016–2017 | National quality improvement registry | People with DM | Preventable hospitalisations | Decreased from 79 to 65.2 per 100,000 individuals |
South Korea | Park [56] | 2006–2015 | National health insurance database | People with DM | Hospitalisation due to vascular complications and mortality |
CVD events declined; hospitalisations due to CHF (per 10,000 individuals) increased from 124 to 161 in women and from 72 to 146 in men; hospitalisations for PAD (per 10,000 individuals) increased from 19 to 35 in women and from 39 to 55 in men Mortality from cancers, CVD, DM and HTN declined but mortality from pneumonia increased |
South Korea | You [57] | 2004–2013 | National health insurance database | Population | Hospitalisation due to hyperglycaemia and in-hospital mortality |
2004–2006: increased (1.8 to 2.6 per 1000 individuals) 2007–2013: decreased (2.5 to 2.2 per 1000 individuals) Mortality declined |
South Korea | Kim [58] | 2011–2016 | National health insurance database | People with diabetic foot | LEA and revascularisation | Total LEAs increased with flat/declining major amputations; revascularisation interventions increased |
Hong Kong | Wu [59] | 2001–2016 | Electronic medical record diabetes registry | People with DM (770,078) | Hospitalisation for LEA |
Decreased (per 10,000 individuals) for minor LEAs (from 14.0 to 7.2 in men [−48.6%] and from 7.9 to 3.2 in women [−59.5%]) and major LEAs (from 19.5 to 4.3 in men [−77.9%] and from 11.6 to 2.4 in women [−79.3%]) Similar findings for newly diagnosed DM and T1DM |
Taiwan | Lin [60] | 2007–2014 | National health insurance database | People with T2DM | Diabetic foot complications (ulcers, infections, gangrene, PAD hospitalisation) |
Decreased LEAs (2.9 to 2.1 per 1000 individuals) Major LEAs declined from 56.2% to 47.4% of all LEAs |
Brazil | Florêncio [61] | 2008–2019 | National hospital registry | Population | Hospitalisation related to DM | Increased hospitalisations, higher in female sex; variation in mortality by region |
The literature included is composed of articles that reported data with international, national or at least subnational coverage and data sources such as registries or administrative/discharge records. This table does not include publications up to 2015 and is intended as an update to prior reviews [3]
CHF, congestive heart failure; CKD, chronic kidney disease; DM, diabetes mellitus; HTN, hypertension; LEA, lower-extremity amputation; PAD, peripheral arterial disease; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus